Skip to main content

Advertisement

Open Peer Review Reports for: Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Jan 2006 Submitted Original manuscript
26 Feb 2006 Reviewed Reviewer Report - Florian Eckel
1 Mar 2006 Reviewed Reviewer Report - Vittorio Gebbia
8 Mar 2006 Reviewed Reviewer Report - Tushar Patel
5 Apr 2006 Author responded Author comments - Martin Franz Sprinzl
Resubmission - Version 2
5 Apr 2006 Submitted Manuscript version 2
3 May 2006 Author responded Author comments - Martin Franz Sprinzl
Resubmission - Version 3
3 May 2006 Submitted Manuscript version 3
3 May 2006 Author responded Author comments - Martin Franz Sprinzl
Resubmission - Version 4
3 May 2006 Submitted Manuscript version 4
12 Jun 2006 Reviewed Reviewer Report - Tushar Patel
15 Jun 2006 Author responded Author comments - Martin Franz Sprinzl
Resubmission - Version 5
15 Jun 2006 Submitted Manuscript version 5
16 Jul 2006 Author responded Author comments - Martin Franz Sprinzl
Resubmission - Version 6
16 Jul 2006 Submitted Manuscript version 6
Publishing
17 Jul 2006 Editorially accepted
17 Jul 2006 Article published 10.1186/1471-2407-6-190

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement